Promising case study for novel immun... - Advanced Prostate...

Advanced Prostate Cancer

22,351 members28,110 posts

Promising case study for novel immunotherapy IMM-101, correction of vitamin D levels plus Bromelain and LDN

Graham49 profile image
6 Replies

The role of immune modulation and anti‑inflammatory agents in the management of prostate cancer: A case report of six patients

Angus G Dalgleish, Wai M Liu

Oncology Letters 24 (2), 1-4, 2022Cancer is associated with chronic inflammation and disruption to normal immune function. As such, the ability to thrive in a chronically inflamed microenvironment is regarded as a hallmark of cancer. Therefore, targeting inflammation and/or correction of aberrant immunity has been a therapeutic aim. The aim of the present study was to describe the use of a novel immunotherapy, called IMM‑101, which is a naturally occurring, heat‑killed whole cell mycobacterium, used in combination with conventional treatments in patients with prostate cancer. The present study analysed and presented data from six patients diagnosed with prostate cancer, some of whom have metastatic disease. Treatment regimens included the use of IMM‑101, the correction of vitamin D3 levels, and combination with other agents that have anti‑inflammatory and immune‑modulatory abilities, such as bromelain and low‑dose naltrexone (LDN). Clinical responses were detected in the patients when IMM‑101 was commenced and further improvements were seen when an anti‑inflammatory agent was used in unison. Combination therapy quickly led to a reduction in prostate‑specific antigen levels, and stabilisation of disease was often achieved as indicated by repeat MRI and PET scans. Few side effects of any kind were observed when using these combination treatments. In conclusion, IMM‑101 treatment alongside an anti‑inflammatory agent, such as bromelain and/or LDN, may be considered an active and safe drug combination, and is a regimen that should be considered for treating patients with prostate cancer.

Written by
Graham49 profile image
Graham49
To view profiles and participate in discussions please or .
Read more about...
6 Replies
6357axbz profile image
6357axbz

What does it say about vitamin D3 levels, quantitatively?

Its better than mice but 6 patients? And they can make claims such as “Clinical responses were detected in the patients when IMM‑101 was commenced and further improvements were seen when an anti‑inflammatory agent was used in unison.”

Graham49 profile image
Graham49 in reply to

That's not a claim, that's an observation.

Graham49 profile image
Graham49

HTTPS://doi.org/10.3892/ol.2022.13367

6357axbz profile image
6357axbz

Thanks

Currumpaw profile image
Currumpaw

I have been taking bromelain for years LDN was prescribed years ago by my conventional/ alternative doc. Of course, vitamin D is or should be tested to keep levels optimal.

Copy the entire script between the lines and place in your search bar.

______________________________________________________________________________________

Bromelain's activity and potential as an anti-cancer agent: …

originalText

______________________________________________________________________________________

Another link below--

_______________________________________________________________________________________

What is Low Dose Naltrexone (LDN)? - LDN Research Trust

originalText

_______________________________________________________________________________________

After accessing the LDN site above go to LDN conditions for cancer info.

Currumpaw

Not what you're looking for?

You may also like...

Extending your survival time:

I would like everyone to understand that Prostate Cancer disease progression is aided by...
Attitude67 profile image

Metformin & Quercetin - Synergy?

New cell & mouse study below [1]. "Our findings showed that metformin in combination with quercetin...
pjoshea13 profile image

Abiraterone / Docetaxel

New video from: "Christopher Sweeney, MBBS, physician, Dana-Farber Cancer Institute, compares...
pjoshea13 profile image

Vitamin D status & inflammation in PCa

New study [1] below. ... "Serum 25-(OH)D was lower in patients with prostate cancer." ......
pjoshea13 profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.